A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas.
BMC Med
; 21(1): 470, 2023 11 29.
Article
in En
| MEDLINE
| ID: mdl-38031088
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoma
Limits:
Humans
Language:
En
Journal:
BMC Med
Journal subject:
MEDICINA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: